gantenerumab (RG1450) - Roche, Novartis
crenezumab (RG7412) - AC Immune
tilavonemab (ABBV-8E12) - AbbVie
Aduhelm (aducanumab) - Neurimmune, Eisai
Leqembi (lecanemab-irmb) - Biogen, Eisai
prasinezumab (RG7935) - Roche
solanezumab (LY2062430) - Eli Lilly
cinpanemab (BIIB054) - Biogen
Kisunla (donanemab-azbt) - Eli Lilly
http://www.ncbi.nlm.nih.gov/pubmed/39313800
 
Abdullrahman Elgarawany; Darin W Aswa; Noha N Lasheen; Rana Mansour; Salma Allam; Ziad Farouk
 
Sep 24, 2024
 
Prev Next